The Vertical Group

The Vertical Group functions as a venture capital firm exclusively focused on investments within medical technology and biotechnology sectors. It specializes in identifying and supporting emerging companies developing innovative healthcare solutions. Its investment strategy leverages principal experience and deep industry knowledge to foster robust portfolio growth.

Founded in 1988, The Vertical Group’s core insight stemmed from its principals' conviction in the transformative potential of medical technology and biotechnology. Key principal Jack Lasersohn cultivated expertise beginning in 1981 at predecessor firm F. Eberstadt. This collective background as seasoned early investors formed the bedrock of the firm’s specialized strategy.

The firm primarily partners with and invests in early-stage medical technology and biotechnology companies, offering capital and strategic guidance. The Vertical Group’s vision is to accelerate the development and commercialization of healthcare innovations addressing unmet medical needs. Its mission remains advancing patient care by backing visionary companies at the forefront of progress.